Health Care [ 7/12 ] | Pharmaceuticals [ 40/74 ]
NYSE MKT | Common Stock
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals.
The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system.
It also provides therapeutic products, including PulseVet electrohydraulic shockwave therapy platform; and Assisi Loop line of products, including the Assisi Loop, Assisi Loop Lounge, and DentaLoop devices that treat pain and inflammation through delivery of targeted pulsed electromagnetic field focused energy.
The company has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for the development of a novel pathogen detection system.
The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020.
Zomedica Corp. is headquartered in Ann Arbor, Michigan.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 7, 24 | -0.01 Decreased by -580.00% | - |
| Aug 14, 24 | -0.02 Decreased by -144.00% | - |
| May 9, 24 | -0.01 Increased by 0.00% | - |
| Feb 13, 24 | -0.01 Increased by 0.00% | - |
| Nov 13, 23 | -0.00 Increased by +80.39% | - |
| Aug 10, 23 | -0.01 Decreased by -100.00% | - |
| May 11, 23 | -0.01 Decreased by -150.00% | - |
| Mar 15, 23 | -0.01 Decreased by -300.00% | -0.01 |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 24 | 7.00 M Increased by +10.24% | -6.70 M Decreased by -1.26 K% | Decreased by -95.71% Decreased by -1.14 K% |
| Jun 30, 24 | 6.13 M Increased by +1.84% | -23.93 M Decreased by -355.92% | Decreased by -390.33% Decreased by -347.66% |
| Mar 31, 24 | 6.26 M Increased by +14.23% | -9.16 M Decreased by -43.46% | Decreased by -146.28% Decreased by -25.59% |
| Dec 31, 23 | 7.34 M Increased by +19.17% | -22.41 M Decreased by -697.65% | Decreased by -305.38% Decreased by -569.37% |
| Sep 30, 23 | 6.35 M Increased by +32.89% | -491.00 K Increased by +90.17% | Decreased by -7.74% Increased by +92.60% |
| Jun 30, 23 | 6.02 M Increased by +41.78% | -5.25 M Increased by +0.46% | Decreased by -87.19% Increased by +29.79% |
| Mar 31, 23 | 5.48 M Increased by +46.15% | -6.38 M Decreased by -62.18% | Decreased by -116.47% Decreased by -10.97% |
| Dec 31, 22 | 6.16 M Increased by +50.88% | -2.81 M Increased by +14.62% | Decreased by -45.62% Increased by +43.41% |